DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

References

Bouillon K, Bertrand M, Maura G, Blotière PO, Ricordeau P, Zureik M.
Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.

Lancet Haematol 2015;
2 (04) e150-e159

Download Bibliographical Data

Access: